Researchers have discovered the ExHOS nanomachine responsible for constitutive exocytosis using advanced microscopy and AI-enhanced image analysis.
Key Details
- 1International team led by Pompeu Fabra University identifies ExHOS, the nanomachine controlling constitutive exocytosis.
- 2Discovery relied on integrating multiple advanced light and electron microscopes with artificial intelligence for image analysis.
- 3ExHOS organizes seven protein assemblies into a flexible ring, mediating molecular package delivery at the cell surface.
- 4ExHOS understanding has implications for infections, rare diseases, and cancer metastasis.
- 5Microscopy and AI enabled visualization of dynamic cellular machinery previously inaccessible by traditional imaging.
Why It Matters
The use of cutting-edge imaging and AI demonstrates the evolving power of bioimaging technologies, paving the way for deeper insights into fundamental biological processes and their medical implications. This integration is directly relevant to radiology and imaging AI professionals interested in high-resolution cellular and molecular imaging advancements.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.